Serum Pepsinogen and Gastric Cancer Screening
スポンサーリンク
概要
- 論文の詳細を見る
Since the 1990's, the test for serum pepsinogen as a marker for chronic atrophic gastritis has been incorporated into gastric cancer screening programs, on a trial basis, to identify people at high risk for gastric cancer. The addition of the serum test to the cancer screening program has been shown to improve the detection rate of cancer and pepsinogen testing is useful in detecting early-stage gastric cancers arising from atrophic gastric mucosa, which macroscopically tend to be elevated and histologically differentiated. Furthermore, the cost for the detection of a single cancer case is much less than that for conventional screening. Thus, with the introduction of pepsinogen testing, complimenting barium X-ray, a more efficient screening system is available.
- 社団法人 日本内科学会の論文
著者
-
OHATA Hiroshi
Second Department of Internal Medicine, Wakayama Medical University
-
Ichinose Masao
Second Department Of Internal Medicine Wakayama Medical University
-
Arii Kenji
Second Department Of Internal Medicine Wakayama Medical University
-
Oka Masashi
Second Department Of Internal Medicine Wakayama Medical University
-
Ohata Hiroshi
Second Department Of Internal Medicine Wakayama Medical University
-
Tamai Hideyuki
Second Department Of Internal Medicine Wakayama Medical University
-
Yanaoka Kimihiko
Second Department Of Internal Medicine Wakayama Medical College
-
Mukoubayashi Chizu
Second Department Of Internal Medicine Wakayama Medical University
関連論文
- Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL NEOPLASMS
- Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis
- Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level
- Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography
- Endothelin-3 controls growth of colonic epithelial cells by mediating epithelial-mesenchymal interaction
- Seronegative Alpha-Fetoprotein-Producing Gastric Cancer : An Early Form of Aggressive Cancer
- Chronic Estrogen Supplementation Following Ovariectomy Improves the Emotional Stress-Induced Cardiovascular Responses by Indirect Action on the Nervous System and by Direct Action on the Heart
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER USING THE TIP OF AN ELECTROSURGICAL SNARE (THIN TYPE)
- Upregulation of Heme Oxygenase-1 in an Animal Model of Takotsubo Cardiomyopathy
- Risk factors for knee osteoarthritis in Japanese men : a case-control study
- Helicobacter pylori infection reduces intraluminal nitric oxide in humans
- Serum Pepsinogen and Gastric Cancer Screening
- Nonparasitic Solitary Giant Hepatic Cyst Causing Obstructive Jaundice was Successfully Treated with Monoethanolamine Oleate
- Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation
- Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
- Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection